For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Naldemedine - Constipation
PAD Profile : Naldemedine - Constipation Important
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Macrogol 3350
- Methylnaltrexone bromide
- Prucalopride
- Naloxegol
- Ispaghula husk
- Bisacodyl
- Docusate sodium
- Glycerol
- Senna
- Lactulose
- Phosphates (Rectal)
- Sterculia
- Co-danthrusate (Dantron/docusate sodium)
- Co-danthramer (Dantron/poloxamer 188)
- Sodium citrate (Rectal)
- Arachis oil
- Magnesium hydroxide
- Sodium picosulfate
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.
Management | Constipation | CKS | NICE
The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.
Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.
The Surrey Heartlands ICS Area Prescribing Committee approves naldemedine as another treatment option for Opioid Induced Constipation (OIC) in line with NICE TA651.
Naldemedine will be given a GREEN traffic light status for this indication.